1. Pharmacogenetic markers of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek, 2019, doctoral dissertation Keywords: Parkinson's disease, pharmacogenetics, dopaminergic treatment, adverse events, genetic polymorphisms, personalized medicine, clinical-pharmacogenetic models Full text (file, 11,02 MB) |
2. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events Full text (file, 411,70 KB) This document has more files! More... |
3. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events Full text (file, 673,75 KB) This document has more files! More... |
4. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Full text (file, 279,78 KB) This document has more files! More... |
5. Reporting of adverse events and the fundamental tasks of manager - a qualitative interview studyKarin Birk Tot, Mirko Markič, Ljubiša Pađen, 2023, original scientific article Keywords: adverse events, health care, management, managers, qualitative study, tasks of managers Full text (file, 375,50 KB) This document has more files! More... |
6. Utilization of potentially inappropriate medication and risk of adverse drug events among older adults with chronic renal insufficiencySafoura Sheikh Rezaei, Hana Šinkovec, Alexander Schöberl, Christoph Rinner, Georg Heinze, Michael Wolzt, Walter E. Gall, 2021, original scientific article Keywords: medications, chronic kidney disease, adverse drug events, pharmaco-epidemiology, older adults Full text (file, 567,21 KB) This document has more files! More... |
7. The prognostic and predictive value of human gastrointestinal microbiome and exosomal mRNA expression of PD-L1 and IFNγ for immune checkpoint inhibitors response in metastatic melanoma patientsAna Erman, Marija Ignjatović, Katja Leskovšek, Simona Miceska, Urša Lampreht Tratar, Maša Omerzel, Veronika Kloboves-Prevodnik, Maja Čemažar, Lidija Kandolf Sekulović, Gorazd Avguštin, Janja Ocvirk, Tanja Mesti, 2023, original scientific article Keywords: gastrointestinal microbiome, mRNA expression of PD-L1 and IFNγ, immune checkpoint inhibitors, metastatic melanoma, predictive and prognostic biomarkers, immune-related adverse events Full text (file, 637,75 KB) This document has more files! More... |